180 Life Sciences

About:

180 Life Sciences developing novel drugs for treating distinct inflammatory diseases.

Website: https://180lifesciences.com/

Description:

180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University, and Stanford University.

Total Funding Amount:

$29.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2013-01-01

Founders:

Lawrence Steinman, Marc Feldmann, Raphael Mechoulam

Number of Employees:

1-10

Last Funding Date:

2023-08-10

IPO Status:

Public

Industries: